Effect of Parecoxib as an Adjunct to Patient-Controlled Epidural Analgesia after Abdominal Hysterectomy: A Multicenter, Randomized, Placebo-Controlled Trial.

This multicenter, randomized, placebo-controlled study evaluated the efficacy and side effects of parecoxib during patient-controlled epidural analgesia (PCEA) after abdominal hysterectomy.A total of 240 patients who were scheduled for elective abdominal hysterectomy under combined spinal-epidural a...

Full description

Bibliographic Details
Main Authors: Wei-Feng Liu, Hai-Hua Shu, Guo-Dong Zhao, Shu-Ling Peng, Jin-Fang Xiao, Guan-Rong Zhang, Ke-Xuan Liu, Wen-Qi Huang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5021366?pdf=render
_version_ 1819155959853875200
author Wei-Feng Liu
Hai-Hua Shu
Guo-Dong Zhao
Shu-Ling Peng
Jin-Fang Xiao
Guan-Rong Zhang
Ke-Xuan Liu
Wen-Qi Huang
author_facet Wei-Feng Liu
Hai-Hua Shu
Guo-Dong Zhao
Shu-Ling Peng
Jin-Fang Xiao
Guan-Rong Zhang
Ke-Xuan Liu
Wen-Qi Huang
author_sort Wei-Feng Liu
collection DOAJ
description This multicenter, randomized, placebo-controlled study evaluated the efficacy and side effects of parecoxib during patient-controlled epidural analgesia (PCEA) after abdominal hysterectomy.A total of 240 patients who were scheduled for elective abdominal hysterectomy under combined spinal-epidural anesthesia received PCEA plus postoperative intravenous parecoxib 40 mg or saline every 12 h for 48 h after an initial preoperative dose of parecoxib 40 mg or saline. An epidural loading dose of a mixture of 6 mL of 0.25% ropivacaine and 2 mg morphine was administered 30 min before the end of surgery, and PCEA was initiated using 1.25 mg/mL ropivacaine and 0.05 mg/mL morphine with a 2-mL/h background infusion and 2-mL bolus with a 15-min lockout. The primary end point of this study was the quantification of the PCEA-sparing effect of parecoxib.Demographic data were similar between the two groups. Patients in the parecoxib group received significantly fewer self-administrated boluses (0 (0, 3) vs. 7 (2, 15), P < 0.001) and less epidural morphine (5.01 ± 0.44 vs. 5.95 ± 1.29 mg, P < 0.001) but experienced greater pain relief compared with the control group (P < 0.001). Patient global satisfaction was higher in the parecoxib group than the control group (P < 0.001). Length of hospitalization (9.50 ± 2.1, 95% CI 9.12~9.88 vs. 10.41 ± 2.6, 95% CI 9.95~10.87, P = 0.003) and postoperative vomiting (17% vs. 29%, P < 0.05) were also reduced in the parecoxib group. There were no serious adverse effects in either group.Our data suggest that adjunctive parecoxib during PCEA following abdominal hysterectomy is safe and efficacious in reducing pain, requirements of epidural analgesics, and side effects.ClinicalTrials.gov (NCT01566669).
first_indexed 2024-12-22T15:45:16Z
format Article
id doaj.art-4d9a014180d24258af10856717e0deb4
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-22T15:45:16Z
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-4d9a014180d24258af10856717e0deb42022-12-21T18:21:02ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01119e016258910.1371/journal.pone.0162589Effect of Parecoxib as an Adjunct to Patient-Controlled Epidural Analgesia after Abdominal Hysterectomy: A Multicenter, Randomized, Placebo-Controlled Trial.Wei-Feng LiuHai-Hua ShuGuo-Dong ZhaoShu-Ling PengJin-Fang XiaoGuan-Rong ZhangKe-Xuan LiuWen-Qi HuangThis multicenter, randomized, placebo-controlled study evaluated the efficacy and side effects of parecoxib during patient-controlled epidural analgesia (PCEA) after abdominal hysterectomy.A total of 240 patients who were scheduled for elective abdominal hysterectomy under combined spinal-epidural anesthesia received PCEA plus postoperative intravenous parecoxib 40 mg or saline every 12 h for 48 h after an initial preoperative dose of parecoxib 40 mg or saline. An epidural loading dose of a mixture of 6 mL of 0.25% ropivacaine and 2 mg morphine was administered 30 min before the end of surgery, and PCEA was initiated using 1.25 mg/mL ropivacaine and 0.05 mg/mL morphine with a 2-mL/h background infusion and 2-mL bolus with a 15-min lockout. The primary end point of this study was the quantification of the PCEA-sparing effect of parecoxib.Demographic data were similar between the two groups. Patients in the parecoxib group received significantly fewer self-administrated boluses (0 (0, 3) vs. 7 (2, 15), P < 0.001) and less epidural morphine (5.01 ± 0.44 vs. 5.95 ± 1.29 mg, P < 0.001) but experienced greater pain relief compared with the control group (P < 0.001). Patient global satisfaction was higher in the parecoxib group than the control group (P < 0.001). Length of hospitalization (9.50 ± 2.1, 95% CI 9.12~9.88 vs. 10.41 ± 2.6, 95% CI 9.95~10.87, P = 0.003) and postoperative vomiting (17% vs. 29%, P < 0.05) were also reduced in the parecoxib group. There were no serious adverse effects in either group.Our data suggest that adjunctive parecoxib during PCEA following abdominal hysterectomy is safe and efficacious in reducing pain, requirements of epidural analgesics, and side effects.ClinicalTrials.gov (NCT01566669).http://europepmc.org/articles/PMC5021366?pdf=render
spellingShingle Wei-Feng Liu
Hai-Hua Shu
Guo-Dong Zhao
Shu-Ling Peng
Jin-Fang Xiao
Guan-Rong Zhang
Ke-Xuan Liu
Wen-Qi Huang
Effect of Parecoxib as an Adjunct to Patient-Controlled Epidural Analgesia after Abdominal Hysterectomy: A Multicenter, Randomized, Placebo-Controlled Trial.
PLoS ONE
title Effect of Parecoxib as an Adjunct to Patient-Controlled Epidural Analgesia after Abdominal Hysterectomy: A Multicenter, Randomized, Placebo-Controlled Trial.
title_full Effect of Parecoxib as an Adjunct to Patient-Controlled Epidural Analgesia after Abdominal Hysterectomy: A Multicenter, Randomized, Placebo-Controlled Trial.
title_fullStr Effect of Parecoxib as an Adjunct to Patient-Controlled Epidural Analgesia after Abdominal Hysterectomy: A Multicenter, Randomized, Placebo-Controlled Trial.
title_full_unstemmed Effect of Parecoxib as an Adjunct to Patient-Controlled Epidural Analgesia after Abdominal Hysterectomy: A Multicenter, Randomized, Placebo-Controlled Trial.
title_short Effect of Parecoxib as an Adjunct to Patient-Controlled Epidural Analgesia after Abdominal Hysterectomy: A Multicenter, Randomized, Placebo-Controlled Trial.
title_sort effect of parecoxib as an adjunct to patient controlled epidural analgesia after abdominal hysterectomy a multicenter randomized placebo controlled trial
url http://europepmc.org/articles/PMC5021366?pdf=render
work_keys_str_mv AT weifengliu effectofparecoxibasanadjuncttopatientcontrolledepiduralanalgesiaafterabdominalhysterectomyamulticenterrandomizedplacebocontrolledtrial
AT haihuashu effectofparecoxibasanadjuncttopatientcontrolledepiduralanalgesiaafterabdominalhysterectomyamulticenterrandomizedplacebocontrolledtrial
AT guodongzhao effectofparecoxibasanadjuncttopatientcontrolledepiduralanalgesiaafterabdominalhysterectomyamulticenterrandomizedplacebocontrolledtrial
AT shulingpeng effectofparecoxibasanadjuncttopatientcontrolledepiduralanalgesiaafterabdominalhysterectomyamulticenterrandomizedplacebocontrolledtrial
AT jinfangxiao effectofparecoxibasanadjuncttopatientcontrolledepiduralanalgesiaafterabdominalhysterectomyamulticenterrandomizedplacebocontrolledtrial
AT guanrongzhang effectofparecoxibasanadjuncttopatientcontrolledepiduralanalgesiaafterabdominalhysterectomyamulticenterrandomizedplacebocontrolledtrial
AT kexuanliu effectofparecoxibasanadjuncttopatientcontrolledepiduralanalgesiaafterabdominalhysterectomyamulticenterrandomizedplacebocontrolledtrial
AT wenqihuang effectofparecoxibasanadjuncttopatientcontrolledepiduralanalgesiaafterabdominalhysterectomyamulticenterrandomizedplacebocontrolledtrial